FactSet Surges 3.62 as $290M Volume Propels It to 356th in Market Activity

On August 20, 2025, FactSet (FDS) closed with a 3.62% gain, trading volume of $290 million—a 54.84% increase from the prior day—ranking 356th in market activity. The move followed its role in providing analyst estimates for Vivos Therapeutics' Q2 2025 earnings report, which highlighted strategic shifts and operational challenges.

Vivos Therapeutics, a medical technology firm, reported a 7.3% revenue decline to $3.8 million, driven by integration costs and a new sales model. FactSet’s data showed operating expenses surged 52% year-over-year, while gross margins fell to 55% due to pricing concessions. These results, attributed to the acquisition of The Sleep Center of Nevada, underscored transitional pressures. FactSet’s inclusion of these figures in its estimates reinforced its relevance in tracking healthcare sector dynamics, potentially influencing investor sentiment toward its data analytics services.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The total profit grew steadily over the past year, with a few fluctuations. As of the latest data, the strategy's profit reached $2,385.14.